Complement factor C5a as mast cell activator mediates vascular remodelling in vein graft disease

Pathophysiology of saphenous vein graft failure: a brief overview of interventions

(2012) Nilima Shukla et al.   CURRENT OPINION IN PHARMACOLOGY

C1-esterase inhibitor protects against early vein graft remodeling under arterial blood pressure

(2011) Paul A.J. Krijnen et al.   ATHEROSCLEROSIS

Complement C5a inhibition reduces atherosclerosis in ApoE−/− mice

(2011) Helga D. Manthey et al.   FASEB JOURNAL

Annexin A5 Therapy Attenuates Vascular Inflammation and Remodeling and Improves Endothelial Function in Mice

(2010) Mark M. Ewing et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis

(2010) H. F. Langer et al.   BLOOD

C5a Receptor Targeting in Neointima Formation After Arterial Injury in Atherosclerosis-Prone Mice

(2010) Erdenechimeg Shagdarsuren et al.   CIRCULATION

The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro

(2010) Walter S. Speidl et al.   FASEB JOURNAL

Molecular Intercommunication between the Complement and Coagulation Systems

(2010) U. Amara et al.   JOURNAL OF IMMUNOLOGY

Short Communication: The Neuropeptide Substance P Mediates Adventitial Mast Cell Activation and Induces Intraplaque Hemorrhage in Advanced Atherosclerosis

(2009) Ilze Bot et al.   CIRCULATION RESEARCH

Complement 5a Receptor Inhibition Improves Renal Allograft Survival

(2008) F. Gueler et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Activated Mast Cells Induce Endothelial Cell Apoptosis by a Combined Action of Chymase and Tumor Necrosis Factor-α

(2007) Hanna M. Heikkilä et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY